Sucralfate Suspension
Product Images NDC 0121-0974

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sucralfate (NDC 0121-0974). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Sucralfate 1)

FDA Label Image

Bottle Label (Sucralfate 2)

Bottle Label (Sucralfate 2)
This is a description of an oral suspension medication called Sucralfate with a concentration of 1g/10mL. The medication is packaged in a non-child-resistant package and is only available with a prescription. The medication should be shaken well before use. The manufacturer of the medication is Pharmaceutical Associates Inc. located in Greenville, SC. The insert for more information is not available.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.